Archive: News
-
A Four-Pillar Program to Preserve Brain Health
A Four-Pillar Program to Preserve Brain Health provides guidelines on maintaining your memory. The program focuses on Physical Health, Emotional Health, Knowledge about your risk for neurological disease, and Actions you should take regarding your health.
Category: News
-
Where Are We in the Search for Better Treatments?
Alzheimer’s Talks host Meryl Comer speaks with one of the nation’s leading Alzheimer’s disease researchers, Dr. R. Scott Turner, director of the Georgetown University Memory Disorders Program, about the current Alzheimer’s drug pipeline and related questions of diagnosis and prevention methods.
Category: News
-
Nicotine may help memory loss
“Oddly a naturally occurring substance that we associate with bad outcomes like smoking, actually if we use it in a different way may turn out to be helpful for us,” said Dr. Newhouse.
Category: News
-
So Far, Just One Thing Has ‘Experimental Support’ In Staving Off Alzheimer’s
“I tell people to go to the gym three to four times a week if they want to prevent Alzheimer’s.” And that along with a healthy diet may well be all we have for now in the wake of so many failed attempts at treating or curing the disease. Still, scientists like Dr. R. Scott Turner, who directs the Memory Disorders Program at Georgetown University Medical Center, are far from giving up the fight.
Category: News
-
Preparing For A Treatment: Alzheimer’s Diagnosis & Care
The Hill will convene key lawmakers, health officials, industry stakeholders, researchers, physicians, patients, and their advocates to continue the conversation about preparing the American health care delivery system for the possibility of a groundbreaking advancement in the treatment of Alzheimer’s. Speakers include Dr. Raymond Turner from the MDP, Senator Ed Markey (D-MA), Senator Thom Tillis (R-NC).
Watch the event recording: ustream.tv/recorded/118452841
Category: News
-
Retired Supreme Court Justice Sandra Day O’Connor announces she is withdrawing from public life because of dementia
Retired Justice Sandra Day O’Connor revealed in a letter on Tuesday that she has been diagnosed with the “beginning stages of dementia, probably Alzheimer’s disease.”
Category: News
-
Studies in Healthy Older People Aim to Prevent Alzheimer’s
PHOENIX (AP) — It may be too late to stop Alzheimer’s in people who already have some mental decline. But what if a treatment could target the very earliest brain changes while memory and thinking skills are still intact, in hope of preventing the disease? Two big studies are going all out to try.
Category: News
-
Alzheimer’s Research Receives Largest Ever Funding Boost in 2019 Budget
WASHINGTON, D.C., September 28, 2018 —The largest-ever funding increase for Alzheimer’s and dementia research at the National Institutes of Health (NIH) was signed into law today. The $425 million increase was advocated for by the Alzheimer’s Association, the Alzheimer’s Impact Movement (AIM) and its nationwide network of dedicated advocates.
Category: News
-
A healthier heart may mean a healthier mind, new study shows
It turns out maintaining low blood pressure does not just help prevent heart attacks — it can also keep your mind sharp.
Research presented Wednesday at the Alzheimer’s Association International Conference in Chicago found that at-risk people whose blood pressure was kept lower than the recommended level had a significant reduction in mild cognitive impairment (MCI), the precursor to dementia.Category: News
-
New Alzheimer’s Drug Slows Memory Loss in Early Trial Results
The long, discouraging quest for a medication that works to treat Alzheimer’s reached a potentially promising milestone on Wednesday. For the first time in a large clinical trial, a drug was able to both reduce the plaques in the brains of patients and slow the progression of dementia.
More extensive trials will be needed to know if the new drug is truly effective, but if the results, presented Wednesday at the Alzheimer’s Association International Conference in Chicago, are borne out, the drug may be the first to successfully attack both the brain changes and the symptoms of Alzheimer’s.Category: News